SEC Form 4 · accession 0001209191-18-040345
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ivor Royston
Director
Period of report
Jun 29, 2018
Accepted (ET)
Jul 2, 2018 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.20 | Jun 29, 2018 | A | 15,000 | A | — | Jun 28, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to the option shall be 100% vested and exercisable on June 28, 2019.